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ABSTRACT
The purpose of this study was to evaluate the differences in the disposition and plasma pharmacokinetic behavior of 
marbofloxacin (MAR) in broiler chickens at different seasons. Chicken broilers (n = 345) were used,  in lots of 5 individuals, 
divided into 6 groups depending on the way of administration, intravenous or oral (dose 2 mg/kg) and the test period. 
Post-administration plasma samples were obtained at different times, intravenously (0.08 to 24 hours) and orally (0.25 to 
120 hours). A liquid-liquid extraction of MAR was performed by high-performance liquid chromatography (HPLC) with 
a fluorescent detector. The plasma concentrations obtained at the different sampling times of each season, were analyzed 
with ANOVA and pharmacokinetic analysis was conducted with the PK Solution 2.0 software. The concentration of 
marbofloxacin in plasma was significantly lower in winter and summer than in spring, with MAR being detected in winter 
up to 72 hours post-application, coinciding with the differences in MAR pharmacokinetics parameters with increase in the 
average residence time (MRT) is 9.4 hours in winter. Increased clearance MAR in summer (7.5 ml/min/kg) coincides with 
MRT 6.3 hours. Finally, the oral bioavailability of MAR is lower in summer and winter (86 ± 1.7% and 78 ± 3.1%) than in 
spring (94 ± 5.2 %). There are differences in the disposition and plasma pharmacokinetic behavior of MAR applied orally 
in broiler chickens, coinciding with the physiological changes in the thermoregulation of birds, considering its correct 
therapeutic management and contributing to provide safe food for human consumption.
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INTRODUCTION
The intensification of the production in poultry 
farms increases the risk of diseases, expending 
the use of antimicrobial prophylactic, control or 
treatment agents (1, 2). Fluoroquinolones which are 
the most used antimicrobial agents in veterinary 
medicine are used intensively in poultry production 
(1, 3).
Marbofloxacin (MAR) is a fluoroquinolone 
effective against a wide range of important poultry 
pathogens, including Mycoplasma gallisepticum, 
Escherichia coli and Pasteurella multocida. It has a 
low plasma protein binding, it benefits from a rapid 
and complete absorption, a broad distribution with 
good concentrations in tissues and bodily fluids, 
a moderate elimination and a high bioavailability, 
which are all ideal pharmacokinetic characteristics 
to use in poultry (4-8).
 There are factors that modify this 
pharmacokinetic behavior such as race, age, weight, 
environmental factors, among others. Failure to 
identify these factors leads to errors in predicting 
the dose-exposure relation within a population (9, 
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10). It is important to know the modifications that 
these factors bring about in the pharmacokinetics 
of drugs in food producing animals, in order to 
improve therapeutic management and generate 
food free of pharmacological residues (11).
Finally, the objective of this study is to 
evaluate the differences in the disposition and 
pharmacokinetic behavior of MAR in broiler 
chickens, administered orally and intravenously, in 
comfort temperature (spring), summer and winter.
MATERIAL AND METHODS
Experimental design
For the study, healthy Ross broiler chickens 
(n=345) were used. They were 30 days old and each 
weighed 0.98 ± 0.02 kg. They were randomly divided 
into 6 groups, a spring group A (n=50) and group 
B (n=65), a summer group C (n=50) and a group D 
(n=65), a winter group E (n=50) and a group F (n=65).
For each time of the year, the chickens were 
placed in a room that maintained the environmental 
conditions of the study station: spring group with an 
ambient temperature of 18.6 ± 2.5 °C, winter group of 
12 ± 2.9 °C and summer group of 26.6 ± 2.3 °C. The 
temperature was recorded every 8 hours during the 
study. The birds received food and water ad libitum.
Chickens were given a single dose of 2 mg/kg 
of Marbocyl 2% (Laboratorio Vétoquinol S.A., 
Spain) applied intravenously or orally, for the latter 
the dose was administrated after 12 hours fasting. 
In groups A, C, E the blood was sampled between 
0.08 to 24 hours, while in groups B, D and F it was 
between 0.25 to 120 hours.
Sample processing
Five chickens were used for each sample 
extraction time. Blood collection (5 ml) was 
performed in the axillary vein, and the blood was 
placed in heparinized tubes and immediately 
centrifuged for 10 minutes at 2,500 rpm, to obtain 
the plasma for the study.
To extract the analyte (MAR), a liquid-liquid 
extraction was used. 200μl of plasma was placed 
in an eppendorf tube, 800μl of methanol, 200μl 
of deionized water and 40μl of enrofloxacin (2.5 
μg/ml) were added as an internal standard. The 
determination was performed by high performance 
liquid chromatography (HPLC, Hewlett-Packard 
1050 equipment), with a fluorescence detector 
(Hewlett-Packard 1046-A) and C-18 column 
(Octadecylsilane 5μm, 250 cm x 4.6 mm). Analytes 
were eluted isocratically with a flow rate of 0.8 ml/min, 
using a mobile phase consisting of deionized water, 
acetonitrile, and triethylamine (790:200:10 v/v/v) 
(12, 13).
Peak areas in chromatograms of the samples 
were quantitated using the internal-standard 
technique, by use of solutions of marbofloxacin 
and reference standard (enrofloxacin). Standard 
curves were linear (r2 > 0.99) for concentrations 
ranging from 0.039 to 1.25 μg/ml of plasma for 
marbofloxacin, and quantification limit was 0.006 
μg/ml and the relative recovery was 86.2 ± 3.75% 
for the ranges 0.0024 - 2.5 μg/ml (12).
Pharmacokinetic analysis
The pharmacokinetic study was performed 
using the Non-compartmental PK Solution 
2.0 pharmacokinetic program (14), also using 
the average MAR concentrations obtained by 
sampling time, the way of administration, and the 
average weight of each study group. In addition, 
marbofloxacin absolute bioavailability (F) for oral 
administration was calculated by comparing areas 
under the intravenous plasma curve (AUCiv) with 
the oral plasma curve (AUCpo) (15).
 Statistical analysis was performed with the 
software InfoStat (16) ANOVA test and Tukey’s 
test to compare plasma concentrations and MAR 
pharmacokinetic parameters between spring 
(control), summer and winter.
RESULTS
Fig. 1 shows the mean plasma concentrations of 
MAR in broilers in different seasons by intravenous 
route and Fig. 2 by oral administration.
Figure 1. Plasma disposition curve concentrations 
of MAR (µg/ml) after intravenous administration in 
chickens (2mg/kg) in different seasons
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MAR concentration by oral application (Fig. 2) 
in winter is significantly lower (p<0.05) than control 
(spring), with a reduction in total concentration of 
46 ± 4.1 %. No statistically significant differences 
were observed with the intravenous administration 
between spring and the other two seasons (p>0.05). 
In Table 1, Cmax is lower 39 ± 5.1 % (p <0.05) 
in winter than in the control period (spring). MAR 
has a significantly slower and lower oral absorption 
(p<0.05) in winter and summer compared to spring, 
which is consistent with the Tmax of 2 hours.
Table 1 shows that the elimination of 
marbofloxacin depends on the season the bird 
has been exposed to. In winter with the oral 
administration (group F) there is an increase in the 
elimination half-life (7.6 ± 1.4 hours), coinciding 
with the increase of the MRT (9.4 ± 0.9 hours), 
determining a slower elimination and greater 
permanence of MAR in the chickens in winter 
compared to spring and summer (p<0.05). On the 
other hand, in summer by oral application of MAR 
(group D), it has a decreased elimination half-life 
(4.9 ± 0.6 hours), which coincides with the short 
MRT of 6.3 ± 0.4 hours.
In summer the total plasma clearance (7.6 ± 
0.1 ml/min/kg) is significantly higher (p<0.05) 
compared to the other two seasons. Oral 
bioavailability of MAR in 86 ± 1.7% and 78 ± 3.1% 
winter chickens was observed, decreased compared 
to the spring of 94 ± 5.2 %.
DISCUSSION
The plasma pharmacokinetic behavior of 
intravenous marbofloxacin at each season of 
the year is similar to the one described by other 
authors (4, 6, 7), with a high oral bioavailability 
which demonstrates that marbofloxacin maintains 
rapid dissolution in the intestinal environment 
characteristic of fluoroquinolones (17). In winter, 
Figure 2. Plasma disposition curve concentrations 
of MAR (µg/ml) after oral administration in chickens 
(2mg/kg) in different seasons
Table 1. MAR pharmacokinetic parameters (mean±sd) after intravenous and oral 2 mg/kg single dose in broiler 
chickens, at spring (A-B), summer (C-D) and winter (D-F)
Pharmacokinetic 
parameters Group A Group C Group E Group B Group D Group F
Cmax (μg/ml) - - - 0.8 ±0.1 0.7 ± 0.1 0.5 ± 0.1*
Tmax (hours) - - - 1.0 ±0.2 2.0 ± 0.0* 2.0 ± 0.0*
t½ abs (hours) - - - 0.1 ± 0.0 0.9 ± 0.1* 0.8 ± 0.1*
t½α(hours) 0.5 ± 0.1 0.7 ± 0.0* 0.5 ±0.0 2.8 ± 0.1 1.4 ± 0.4* 3.2 ±0.1
t½β(hours) 6.5 ±0.4 5.3±0.4* 5.0 ± 0.3* 4.7 ± 0.8 4.9 ± 0.6 7.6 ± 1.4*
AUC(μg-h/ml) 5.0 ± 0.55 4.3±0.1* 5.2 ± 0.15 4.7 ±0.3 3.7 ±0.17* 4.1 ± 0.1*
F (%) - - - 94.0 ± 5.2 86.0 ± 1.7 78.0 ± 3.1
Vdarea(L/kg) 3.7 ±0.3 3.5±0.1 2.7 ± 0.2* 2.8 ±0.5 3.3 ± 0.5 4.3 ± 0.7*
MRT (hours) 6.6 ± 0.2 4.3±0.0* 4.9 ± 0.3* 4.9 ±0.1 6.3 ± 0.4* 9.4 ± 0.9*
Clt (ml/min/kg) 6.6 ±0.4 7.6±0.1* 6.3 ± 0.1 6.5 ±0.3 7.5 ± 0.0* 6.3 ± 0.2
Abbreviations: Cmax, maximum plasma concentration; Tmax, time to peak concentration; t½abs, absorption half-life; t½α distribution 
half-life; t½β elimination half-life; AUC, area under the curve; F (%), bioavailability; Vd area, volume of distribution; MRT, mean 
residence time and Clt, total plasma clearance. (*)Statistically significant differences (p<0.05) between the control group (A-B) 
and the study periods (C, D, E, F)
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the detection of MAR in plasma is extended to 72 
hours post application.
The rapid oral absorption, wide distribution 
and moderate elimination of MAR observed in 
birds in the spring is similar to that obtained 
by other authors (4, 6, 7). The oral absorption of 
MAR in summer and winter is slower and smaller 
compared to spring. A decrease of 15 ± 0.8% and 
39 ± 5.1% of Cmax was observed in both summer 
and winter, coinciding with the decrease in oral 
bioavailability. This is due to the low hardiness of 
chickens to ambient temperature variations, with 
an ideal range between 18 to 22 °C (18). This leads 
to rapid thermoregulatory physiological responses, 
such as slowing and diminution of the intestinal and 
stomach peristaltic movements, without modifying 
those of the proventriculus (19, 20). 
There is evidence that fattening chickens 
exposed to temperatures of 31°C present alteration 
in the enterocytes and intestinal mucosa, reducing 
the absorption capacity (21), which may be due to 
the decrease in bioavailability of marbofloxacin in 
summer.
The pharmacokinetic parameters of 
marbofloxacin: clearance, elimination half-life 
(t2/1β) and MRT (Table 1) by intravenous and oral 
application, determine that the elimination of MAR 
in broiler chickens is faster in summer due to the 
physiological changes that the organism exerts to 
non-evaporative heat loss, by increasing water 
consumption and urine production (19).
The physiological mechanism of thermoregulation 
in birds is regulated on the one hand by the vasomotor 
system. In cold situations, peripheral vasoconstriction 
is present to irrigate the most important organs (brain, 
liver, lungs, etc.), explaining the greater persistence of 
MAR in winter (72 hours), whereas in heat situations 
peripheral vasodilation and increased blood flow 
velocity are developed, eliminating non-evaporative 
heat (19, 22), coinciding with the rapid elimination of 
MAR in summer (48 hours).
The rapid elimination of antibiotics in summer 
was not observed by Nawaz (23) in sheep for 
sulphadimidine, rather a slower elimination 
in summer, assigning this difference to the 
physiological difference in the thermoregulation of 
birds and mammals.
Finally, Sun et al. (24) in Paralichthysolivaceus 
worked with different water temperatures and 
the pharmacokinetic behavior of difloxacin, 
concluding like our study that in summer there is 
a significantly higher rate of drug clearance and 
decreased half-life elimination, which coincides 
with the pharmacokinetic results of our study.
CONCLUSION 
The conclusion is that in summer and winter 
there is a decrease in the plasma concentrations 
of marbofloxacin by oral application in broiler 
chickens compared to spring, significantly 
modifying the pharmacokinetic parameters.
It was determined that the therapeutic use 
of marbofloxacin in broiler chickens varies 
according to the season of the year, probably due 
to the physiological thermoregulatory responses 
of the bird to the ambient temperatures. It is of 
importance in later studies to see if it modifies 
the pharmacological residues that can have 
repercussions in humans as animal producing food. 
This last point will be investigated in future studies.
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